Peers: ILMN QSI TXG LAB TMO BRKR BNGO QGEN TWST SEER

| Held by: ARKE ARKK ARKG VTI IWM VXF IWO IBB VTWO SCHA

Index	RUT
Market Cap	761.54M
Enterprise Value	1.23B
Income	-131.39M
Sales	159.27M
Book/sh	-0.11
Cash/sh	0.76
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	485
IPO	Oct 27, 2010

P/E	-
Forward P/E	-
PEG	-
P/S	4.78
P/B	-
P/C	3.21
P/FCF	-
EV/EBITDA	-
EV/Sales	7.73
Quick Ratio	4.03
Current Ratio	4.92
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.43
EPS next Y	-0.45
EPS next Q	-0.13
EPS this Y	74.02%
EPS next Y	5.29%
EPS next 5Y	41.41%
EPS past 3/5Y	-9.18% -
Sales past 3/5Y	7.64% 15.19%
EPS Y/Y TTM	75.85%
Sales Y/Y TTM	2.02%
EPS Q/Q	-3.08%
Sales Q/Q	-1.91%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	0.00% -2.31%

Insider Own	8.56%
Insider Trans	-2.52%
Inst Own	53.87%
Inst Trans	1.08%
ROA	-16.66%
ROE	-929.32%
ROIC	-19.56%
Gross Margin	34.29%
Oper. Margin	-101.67%
Profit Margin	-82.49%
SMA20	8.74%
SMA50	38.99%
SMA200	52.83%
Trades

Shs Outstand	310.81M
Shs Float	284.22M
Short Float	16.51%
Short Ratio	4.18
Short Interest	46.93M
52W High	3.43 -28.68%
52W Low	1.07 128.97%
Volatility	10.80% 14.01%
ATR (14)	0.22
RSI (14)	63.28
Beta	2.24
Rel Volume	0.04
Avg Volume	11.22M
Volume	22,182

Perf Week	14.49%
Perf Month	33.88%
Perf Quarter	65.54%
Perf Half Y	66.67%
Perf YTD	31.02%
Perf Year	24.37%
Perf 3Y	-65.54%
Perf 5Y	-90.82%
Perf 10Y	-71.24%
Recom	2.25
Target Price	2.54
Prev Close	2.45
Price	2.45
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Neutral	$1.35
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31

Show Previous Ratings

Oct-27-26 06:58PM	PacBio's SPARCnext Transition Faces Its First Real Test After Three Straight Guidance Cuts (Earnings Whispers) +8.89%
04:05PM	PacBio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-19-26 09:05AM	PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI (GlobeNewswire) +6.36%
Oct-14-26 04:05PM	PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire)
Oct-06-26 11:51AM	PacBio Sinks 8% as TychoBio Endorses Its Highest Quality Biological Data the Real Story Is More Complicated (TIKR) -5.92%
09:05AM	Loading…
09:05AM	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (GlobeNewswire)
Oct-01-26 11:44AM	3 Biotech Stocks Put Traders Are Targeting Today (Schaeffer's Research) +5.91%
Sep-03-26 04:05PM	PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference (GlobeNewswire)
Aug-05-26 04:46PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press) -9.72% -10.38%
04:08PM	PacBio Appoints Mark Van Oene as President and Chief Executive Officer (GlobeNewswire)
04:05PM	PacBio Announces Second Quarter 2026 Financial Results (GlobeNewswire)
09:05AM	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system (GlobeNewswire)
Jul-28-26 04:05PM	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-15-26 04:05PM	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com)
09:05AM	Loading…
May-26-26 09:05AM	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing (GlobeNewswire)
May-21-26 04:05PM	PacBio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +5.04%
May-19-26 09:00AM	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology (Business Wire)
May-11-26 09:05AM	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss (GlobeNewswire)
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press) -14.55%
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
09:20AM	Loading…
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Oct 06 '26	Option Exercise	1.18	500,000	590,000	1,745,663	Oct 08 04:07 PM
Gibson James R II	See Remarks	Oct 06 '26	Sale	3.11	661,815	2,056,921	1,083,848	Oct 08 04:07 PM
Jim Gibson	Officer	Oct 06 '26	Proposed Sale	2.87	661,815	1,899,409		Oct 06 04:23 PM
Van Oene Mark	See Remarks	Aug 17 '26	Sale	1.13	26,911	30,409	2,705,853	Aug 18 08:17 PM
MARK VAN OENE	Officer	Aug 17 '26	Proposed Sale	1.13	26,911	30,512		Aug 17 04:08 PM
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

CEOMr. Mark Van Oene Ph.D.

CFO & Principal Accounting OfficerMr. James R. Gibson II

Senior Business Advisor & DirectorMr. Christian O. Henry M.B.A.

Co-FounderDr. Stephen Turner Ph.D.

Ph.D.Dr. Brett Atkins J.D.

Open in Screener

MRNA

Moderna Inc

204.44

Oct 28 • 8:55 AM ET -3.53 (-1.70%)

Healthcare Biotechnology USA Large NASD

Peers: BNTX NVAX PCVX ALNY ARCT REGN VALN IONS VIR MRVI

| Held by: VTI VOO QQQ IVV SPY VB VO IBB XLV CGGR

Index	NDX, S&P 500
Market Cap	81.62B
Enterprise Value	77.77B
Income	-3.15B
Sales	2.23B
Book/sh	16.94
Cash/sh	12.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4700
IPO	Dec 07, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	36.63
P/B	12.07
P/C	15.89
P/FCF	-
EV/EBITDA	-
EV/Sales	34.91
Quick Ratio	2.18
Current Ratio	2.29
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-7.98
EPS next Y	-4.76
EPS next Q	-1.11
EPS this Y	-15.98%
EPS next Y	43.53%
EPS next 5Y	26.78%
EPS past 3/5Y	- -29.93%
Sales past 3/5Y	-53.32% 19.33%
EPS Y/Y TTM	-6.22%
Sales Y/Y TTM	-27.62%
EPS Q/Q	7.60%
Sales Q/Q	2.11%
Earnings	Nov 06 BMO
EPS/Sales Surpr.	3.06% 40.87%

Insider Own	8.52%
Insider Trans	-2.51%
Inst Own	80.34%
Inst Trans	1.97%
ROA	-27.43%
ROE	-39.00%
ROIC	-39.41%
Gross Margin	12.57%
Oper. Margin	-149.01%
Profit Margin	-141.43%
SMA20	-3.28%
SMA50	13.86%
SMA200	141.34%
Trades

Shs Outstand	399.00M
Shs Float	365.20M
Short Float	8.93%
Short Ratio	1.57
Short Interest	32.60M
52W High	254.48 -19.66%
52W Low	22.28 817.59%
Volatility	16.26% 10.90%
ATR (14)	20.64
RSI (14)	51.58
Beta	1.19
Rel Volume	0.15
Avg Volume	20.82M
Volume	161,108

Perf Week	-16.83%
Perf Month	0.48%
Perf Quarter	252.97%
Perf Half Y	347.16%
Perf YTD	593.25%
Perf Year	706.47%
Perf 3Y	184.30%
Perf 5Y	-41.24%
Perf 10Y	-
Recom	3.04
Target Price	138.47
Prev Close	207.97
Price	204.44
Change %	-1.70%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-26	Downgrade	William Blair	Outperform → Mkt Perform
Sep-30-26	Downgrade	Citigroup	Neutral → Sell	$80
Sep-03-26	Downgrade	Rothschild & Co Redburn	Neutral → Sell	$81
Aug-28-26	Upgrade	Argus	Hold → Buy	$180
Aug-25-26	Upgrade	Wolfe Research	Underperform → Peer Perform
Aug-19-26	Upgrade	William Blair	Mkt Perform → Outperform
Aug-19-26	Upgrade	BofA Securities	Underperform → Neutral
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform

Show Previous Ratings

Oct-27-26 11:30AM	Scancell cancer vaccine strategy backed by Moderna and Merck trial results (Proactive)
09:19AM	Moderna shares slip as William Blair cuts rating on valuation after rally (Investing.com)
09:00AM	Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot. (Barrons.com)
06:00AM	Oracle, IBM and Intel Have Opted Out of OKX-ICE Stock Tokens, Venues Own Notice Shows (Unchained)
Oct-26-26 06:22PM	Moderna CEO Says Its Cancer Vaccine Isn't a Disappointment, It's a Blockbuster (Barrons.com)
03:17PM	Loading…
03:17PM	Modernas Rally May Have Run Out of Steam. Heres What to Watch Next (Investopedia)
11:58AM	ESMO 26: A cancer vaccine debate, Roches KRAS progress and Amgens unprecedented data (BioPharma Dive)
10:52AM	Moderna's Cancer Vaccine Rally Hits a Wall. This Other Drugmaker Stole the Show. (Barrons.com)
10:28AM	Moderna Recovers From 10% Dive, But Muted Expectations Haunt Cancer Vaccine (Investor's Business Daily)
09:50AM	The excitement around Moderna's cancer vaccine is cooling. Here's why. (MarketWatch)
07:56AM	Premarket movers: Moderna, Brazil ADRs drop; SpaceX rises (Investing.com)
Oct-25-26 12:01PM	Wells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks (decrypt)
Oct-24-26 05:30AM	Moderna Investors Should Brace for More Whiplash (The Wall Street Journal)
Oct-23-26 07:00PM	Moderna's Cancer Vaccine Success Doesn't Live Up to Early Hype (The Wall Street Journal)
04:36PM	Moderna stock extends losses as investors digest melanoma vaccine trial data (Yahoo Finance)
03:02PM	Loading…
03:02PM	Moderna Executives Sold Shares in Trades Planned Before Vaccine Results (The Wall Street Journal)
02:58PM	The real test for Moderna's cancer vaccine isn't about beating Keytruda. It's keeping cancer from coming back in the long term. (MarketWatch)
02:29PM	Investing.coms stocks of the week (Investing.com)
12:16PM	Merck And Moderna Diverge On Cancer Vaccine Results. Do They Still Have A Viable Drug? (Investor's Business Daily)
12:06PM	Moderna trims losses as investors digest melanoma vaccine trial data (Yahoo Finance)
11:33AM	Merck CEO Plays Down Cost Concerns Over Intismeran We Don't See Cost As A Limit To Access (Stocktwits)
10:06AM	Moderna's Cancer-Vaccine Leak Spurred Panic Selling as Wall Street Wanted a Cure (Barrons.com)
09:49AM	Moderna stock extends decline after leaked data on melanoma vaccine trial (Yahoo Finance)
09:42AM	Stocks extend declines, 10-year Treasury holds below 5%: AlphaCheck (Yahoo Finance)
09:04AM	MRNA Stock: Citi Questions Whether Melanoma Vaccines Benefit Justifies Individualized Tumor Harvesting And Manufacturing (Stocktwits)
08:57AM	Moderna Stock Cools After Cancer Vaccine Data Leak (Schaeffer's Research)
08:54AM	ESMO26: MSD and Moderna drop cancer vaccine trial data early (Clinical Trials Arena)
07:41AM	Stock Market Reels From 2 World-Changing Factors (Barrons.com)
07:24AM	The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners? (MarketWatch)
07:00AM	Moderna Named a Top Employer by Science for Twelfth Consecutive Year (ACCESSWIRE)
06:45AM	Loading…
06:45AM	Moderna, Meta, SpaceX, AT&T, CoreWeave, Sandisk, and More Stocks That Explain Today's Market (Barrons.com)
06:17AM	Deckers trips up after earnings, and other early market movers (MarketWatch)
06:13AM	Nasdaq, Dow, S&P 500 Futures Drop Premarket: NVDA, AMD, META, CRWV, MRNA, WDC, BE In Focus (Stocktwits)
04:24AM	Moderna stock crashes as leaked melanoma data threatens its record August rally (Yahoo Finance)
12:51AM	Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations (BeInCrypto)
Oct-22-26 09:28PM	MRNA Stocks Vaccine Rally Cracks As Worst Week In 3 Months Looms Analyst Calls It A Do-Not-Trade Over Wild Swings (Stocktwits) -17.57%
07:44PM	Nasdaq 100 Clocks Worst Day In Four Months As Investors Grow Weary Of Capex, Elevated Debt META, SPCX, BE, MRNA In Focus (Stocktwits)
04:50PM	Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data (Investopedia)
04:45PM	MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes (Stocktwits)
04:18PM	Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat (Reuters)
03:33PM	Details of Moderna's Breakthrough Cancer Vaccine Got Leaked. Its Stock is Plunging. (International Business Times)
03:27PM	Moderna, Merck shares fall on eagerly anticipated cancer vaccine results (BioPharma Dive)
03:21PM	Moderna tumbles to become the worst-performing stock in S&P 500 (MarketWatch)
02:59PM	Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA (pembrolizumab) at ESMO 2026 Presidential Symposium (Business Wire)
02:52PM	Moderna Stock Crashes 25% After Cancer-Vaccine Data Leak (Barrons.com)
02:43PM	Moderna's Shares Plummet After Cancer-Vaccine Data Shared on Social Media (The Wall Street Journal)
02:43PM	Moderna Shares Plunge After Vaccine Data Was Shared on Social Media (The Wall Street Journal)
02:36PM	Moderna Stock Plunges as Apparent Leak Reveals Phase 3 Melanoma Vaccine Data (InvestorsHub)
02:09PM	Moderna Cancer-Vaccine Data Leaks Early, Shares Plummet (The Wall Street Journal)
02:03PM	Moderna's stock tumbles after reported leak of data for cancer vaccine (MarketWatch)
01:50PM	Moderna shares plunge on cancer vaccine data leak (Investing.com)
01:34PM	Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data (Investor's Business Daily)
01:24PM	Moderna, Merck Shares Fall After Possible Melanoma Data Leak (Bloomberg)
08:22AM	Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. (MarketWatch)
12:01AM	Why Did MRNA, CVX, V Stocks Jump To 52-Week Highs Today? (Stocktwits)
Oct-21-26 04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
05:30AM	Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market (The Wall Street Journal)
Oct-20-26 05:14PM	Dow outperforms as Wall Street rises, healthcare stocks lead gains (Reuters) +6.69%
04:35PM	OpenAI acquires startup Orchestra Bio to beef up its biotech business (TechCrunch)
02:41PM	The Healthcare Sector Nears a New High. These Stocks Are Leading the Charge. (Barrons.com)
02:35PM	OpenAI acquires Orchestra Bio to boost drug development AI, Axios reports (Investing.com)
01:08PM	Healthcare sector rallies to record high, even with the broad market gains (MarketWatch)
Oct-18-26 11:15PM	Stocktwits Pharma Pulse: Moderna-Merck Cancer Vaccine Grabs Spotlight As Kidney-Cancer And MS Data Pour In (Stocktwits)
Oct-16-26 03:36PM	Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather (Barrons.com) -7.82%
11:22AM	Moderna stock sinks as Wall Street turns cautious following blistering rally (Yahoo Finance)
10:44AM	What Is The Case For Waiting On Moderna Stock? (Trefis)
09:15AM	This week in charts: Modernas massive stock run (BioPharma Dive)
Oct-15-26 11:18PM	Why Did MRNA, KO, V Stocks Climb To 52-Week Highs Today? (Stocktwits)
03:42PM	MRNA Stock Hits Fresh 52-Week Highs As Goldman Raises Target Ahead Of Melanoma Vaccine Data (Stocktwits)
Oct-14-26 09:46AM	Verastem Is Getting a New CEO, $250 Million, and a Shot at Another Cancer Drug (Barrons.com)
Oct-13-26 07:00AM	Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026 (ACCESSWIRE)
Oct-12-26 10:23PM	Moderna Stock Soared 14% as NIH Plans COVID-Style Push for Cancer Vaccines (TIKR) -5.00%
05:01PM	Where Could Moderna's Next Growth Come From? (Trefis)
01:33PM	Moderna stock surges more than 600% in 2026 (Quartz)
09:42AM	Tech slumps as oil prices rise, focus turns to earnings season kickoff: AlphaCheck (Yahoo Finance)
09:04AM	Moderna Stock Has Been on a Winning Streak (The Wall Street Journal)
05:01AM	Stock Market Today: Diesel Prices Slip on Trump Push for Russia-Ukraine Truce (The Wall Street Journal)
Oct-11-26 11:03PM	Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
Oct-10-26 06:23PM	A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year (BeInCrypto)
09:19AM	Flu season is already here. Here's what to know about this year's flu shots. (MarketWatch)
Oct-09-26 08:09PM	BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits) +14.21% -5.00%
04:23PM	MRNA Stock Sets New 52-Week High As Nasdaq-100 Reentry Meets NIH Cancer-Vaccine Push (Stocktwits)
04:13PM	Moderna stock hits 4-year high on planned national cancer vaccine effort (Yahoo Finance)
12:14PM	Moderna stock jumps on planned national cancer vaccine effort (Yahoo Finance)
Oct-07-26 04:19PM	Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets (Investopedia)
10:43AM	CPHI 2026: Moderna builds on its COVID-era manufacturing lessons (Pharmaceutical Technology)
06:26AM	Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility (InvestorsHub)
Oct-06-26 05:04PM	Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare. (Barrons.com) -7.75%
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
04:38PM	Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers (Investor's Business Daily)
Oct-05-26 11:34PM	NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' (Stocktwits) +6.95%
07:42PM	NVAX Stock Outruns Moderna As Vaxcytes Shot Clears A Late-Stage Test (Stocktwits)
03:30PM	MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns (Stocktwits)
12:01AM	Grail Jumps as Cancer Test Nears Market (The Daily Upside)
Oct-03-26 02:31PM	Merck Stock Is Up 61% in a Year. Is There Room Left to Run? (TIKR)
Oct-02-26 06:43AM	Warner Bros. Stock Is About to Leave the Nasdaq. Here's What's Replacing It. (Barrons.com)
05:51AM	Nike, ON Semi, Moderna, and More Stocks That Explain Today's Market (Barrons.com)
04:31AM	Nasdaq, S&P 500, Dow Futures Rise Ahead Of Jobs Report: NKE, META, RKLB, MRNA, SLS, TSLA Stocks In Focus (Stocktwits)
03:02AM	SLS, IBRX Stocks Climb Overnight: Retail Eyes Modernas Rally As MRNA Lands A Nasdaq-100 Spot (Stocktwits)
Oct-01-26 12:21PM	After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move (Investor's Business Daily)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	Oct 14 '26	Option Exercise	12.21	76,453	933,491	1,638,482	Oct 16 04:09 PM
Hoge Stephen	President	Oct 15 '26	Option Exercise	12.21	76,452	933,479	1,675,710	Oct 16 04:09 PM
Hoge Stephen	President	Oct 15 '26	Sale	220.72	39,145	8,640,084	1,636,565	Oct 16 04:09 PM
Hoge Stephen	President	Oct 14 '26	Sale	213.48	39,224	8,373,453	1,599,258	Oct 16 04:09 PM
Hoge Stephen	Officer	Oct 15 '26	Proposed Sale	220.72	39,145	8,640,033		Oct 15 10:32 AM
Hoge Stephen	Officer	Oct 14 '26	Proposed Sale	213.48	39,224	8,373,519		Oct 14 09:58 AM
Hoge Stephen	President	Sep 14 '26	Option Exercise	12.21	76,453	933,491	1,566,152	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Option Exercise	12.21	76,452	933,479	1,602,310	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Sale	146.07	40,281	5,883,846	1,562,029	Sep 16 04:48 PM
Hoge Stephen	President	Sep 14 '26	Sale	144.13	40,294	5,807,574	1,525,858	Sep 16 04:48 PM
Hoge Stephen	Officer	Sep 15 '26	Proposed Sale	146.07	40,281	5,883,709		Sep 15 10:46 AM
Mock James M	Chief Financial Officer	Sep 10 '26	Option Exercise	30.96	19,836	614,123	94,211	Sep 14 04:25 PM
Mock James M	Chief Financial Officer	Sep 10 '26	Sale	134.49	34,836	4,685,094	59,375	Sep 14 04:25 PM
Hoge Stephen	Officer	Sep 14 '26	Proposed Sale	144.13	40,294	5,807,746		Sep 14 02:39 PM
Mock James M	Officer	Sep 10 '26	Proposed Sale	134.49	34,836	4,685,094		Sep 10 10:14 AM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Option Exercise	30.96	3,471	107,462	77,600	Sep 03 04:56 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Sale	139.95	3,471	485,766	74,129	Sep 03 04:56 PM
Klinger Shannon Thyme	Officer	Sep 01 '26	Proposed Sale	139.95	3,471	485,766		Sep 01 11:22 AM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Option Exercise	19.15	499,246	9,560,561	6,687,037	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 06 '26	Option Exercise	19.15	252,469	4,834,781	6,440,260	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Sale	57.52	499,246	28,715,011	6,187,791	Aug 07 04:11 PM
Bancel Stephane	Officer	Aug 05 '26	Proposed Sale	58.00	499,246	28,956,268		Aug 05 01:02 PM
Hoge Stephen	President	Jul 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jul 16 04:45 PM
Hoge Stephen	President	Jul 15 '26	Sale	67.60	53,336	3,605,514	1,483,848	Jul 16 04:45 PM
Hoge Stephen	Officer	Jul 15 '26	Proposed Sale	67.60	53,336	3,605,514		Jul 15 10:22 AM
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Operating OfficerMr. Juan Andres

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your Finviz experience